...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: The crick didn’t rise, here’s the presentation, finally!

Thanks Payzone, A rec doesn't do your post(s) justice imo.

You have a wonderful understanding of things in this arena & it is very much appreciated.

Share
New Message
Please login to post a reply